Terremoto Biosciences
Agent56 out of 100, Top 25%. Agent Readiness. Open the scores section.Agent Readiness: 56/100. Top 25%. Measured by StartupHub.ai. Median 41.Trust82 out of 100, Top 25%. Data Trust. Open the scores section.Data Trust: 82/100. Top 25%. Measured by StartupHub.ai. Median 61.Developing highly targeted, small molecule medicines.
About
Terremoto Biosciences is a biotechnology company redefining small-molecule therapeutics through cutting-edge medicinal chemistry and novel covalency technologies. They engineer next-generation oral medicines designed for superior efficacy and patient outcomes, aiming to set new class standards for targets with historically narrow therapeutic windows. The company seeks to deliver transformative therapies to patients by pursuing "undruggable" targets.
Similar companies
AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.
Shares Drug Discovery
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Shares Biotechnology, Drug Discovery
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- terremotobio.com
- Headquarters
- South San Francisco, California, USA
- Employees
- 54
- Total funding
- $108M (Series C)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 15 Apr 2026 | Series C | $108M |
Tech stack
Detected on terremotobio.com, last scanned 5 Nov 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- SEO
- All in One SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
- Cookie consent
- Cookiebot
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Terremoto Biosciences trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Terremoto Biosciences is 82 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Terremoto Biosciences raised?
Terremoto Biosciences has raised a total of $108M in funding. The most recent round on record is Series C.
How many employees does Terremoto Biosciences have?
Terremoto Biosciences has approximately 54 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Terremoto Biosciences:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
